Metagenomi, Inc. Common Stock / Fundamentals

    Income statement

    Net revenue
    €29.14M
    Cost of goods sold
    €0.00
    Gross profit
    €29.14M
    SG&A expenses
    €24.61M
    R&D expenses
    €83.77M
    EBITDA
    -€74.48M
    D&A
    €4.76M
    EBIT
    -€79.24M
    Interest expenses
    €0.00
    EBT
    -€77.92M
    Tax expenses
    -€2.74M
    Net income
    -€75.19M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €1.65M
    Changes in working capital
    -€24.17M
    Operating cash flow
    -€83.72M
    Capex
    €1.68M
    Other investing cash flow
    €1.61M
    Net investing cash flow
    €54.73M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    -€330.54K
    Debt repayment
    €0.00
    Other financing cash flow
    -€209.72K
    Net financing cash flow
    -€634.33K
    Foreign exchange effects
    €0.00
    Net change in cash
    -€29.63M
    Cash at end of period
    €27.70M
    Free cash flow
    -€82.04M

    Balance sheet

    Cash and cash equivalents
    €23.17M
    Cash and short-term investments
    €176.92M
    Total receivables
    €1.96M
    Inventory
    €0.00
    Other current assets
    €3.81M
    Total current assets
    €182.69M
    Property, plant & equipment
    €45.22M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €6.39M
    Other non-current assets
    €694.74K
    Total non-current assets
    €52.30M
    Total assets
    €234.99M
    Accounts payable
    €2.50M
    Short-term debt
    €4.75M
    Other current liabilities
    €5.11M
    Total current liabilities
    €28.71M
    Long-term debt
    €64.70M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €1.86M
    Total non-current liabilities
    €37.27M
    Total liabilities
    €65.98M
    Common stock
    €3.45K
    Retained earnings
    -€231.25M
    Other equity
    €321.05K
    Total equity
    €169.01M
    Total liabilities and shareholders' equity
    €234.99M

    Company information

    Market capitalization
    €46.55M
    Employees
    202
    Enterprise Value
    €70.94M

    Company ratios

    Gross margin
    100.0%
    EBITDA margin
    -255.6%
    EBIT margin
    -271.9%
    EBT margin
    -267.4%
    Net margin
    -258.0%
    ROE
    -44.5%
    ROA
    -32.0%
    Asset turnover
    12.4%
    FCF margin
    -293.0%
    FCF yield
    -183.5%
    Efficiency ratio
    355.6%
    Net sales per employee
    €144.27K
    Net income per employee
    -€372.21K

    Notifications